2666 Stock Overview
Offers financing and advisory services in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Genertec Universal Medical Group Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.90 |
| 52 Week High | HK$5.87 |
| 52 Week Low | HK$3.71 |
| Beta | 0.67 |
| 1 Month Change | 5.38% |
| 3 Month Change | 7.69% |
| 1 Year Change | 16.67% |
| 3 Year Change | -11.71% |
| 5 Year Change | -16.95% |
| Change since IPO | -2.00% |
Recent News & Updates
Earnings Working Against Genertec Universal Medical Group Company Limited's (HKG:2666) Share Price
Oct 09
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Recent updates
Earnings Working Against Genertec Universal Medical Group Company Limited's (HKG:2666) Share Price
Oct 09Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking
May 10Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E
Feb 05Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34
Jun 08Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 08Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 31Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?
Aug 20Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching
Apr 19Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return
Mar 10Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?
Feb 19Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?
Feb 01
The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?
Jan 11What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?
Dec 21Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years
Nov 30Shareholder Returns
| 2666 | HK Diversified Financial | HK Market | |
|---|---|---|---|
| 7D | 2.5% | -0.7% | 0.8% |
| 1Y | 16.7% | -1.2% | 21.1% |
Return vs Industry: 2666 exceeded the Hong Kong Diversified Financial industry which returned -1.2% over the past year.
Return vs Market: 2666 underperformed the Hong Kong Market which returned 21.1% over the past year.
Price Volatility
| 2666 volatility | |
|---|---|
| 2666 Average Weekly Movement | 5.3% |
| Diversified Financial Industry Average Movement | 8.8% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 2666 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2666's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 21,521 | Wang Wenbing | www.umcare.cn |
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People’s Republic of China. It operates in two segments, Finance Business and Healthcare Business. The Finance Business segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services.
Genertec Universal Medical Group Company Limited Fundamentals Summary
| 2666 fundamental statistics | |
|---|---|
| Market cap | HK$9.17b |
| Earnings (TTM) | HK$2.19b |
| Revenue (TTM) | HK$14.05b |
4.2x
P/E Ratio0.7x
P/S RatioIs 2666 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2666 income statement (TTM) | |
|---|---|
| Revenue | CN¥13.20b |
| Cost of Revenue | CN¥8.89b |
| Gross Profit | CN¥4.31b |
| Other Expenses | CN¥2.25b |
| Earnings | CN¥2.06b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.09 |
| Gross Margin | 32.66% |
| Net Profit Margin | 15.61% |
| Debt/Equity Ratio | 224.9% |
How did 2666 perform over the long term?
See historical performance and comparisonDividends
6.9%
Current Dividend Yield29%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 23:17 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Genertec Universal Medical Group Company Limited is covered by 16 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BOCOM International Securities Limited |
| Yolanda Yin | CGS International |
| Yolanda Yin | China Galaxy International Securities (Hong Kong) |